Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: 'Gender diversity is crucial for businesses’ growth and performance'

The strength of any organization lies in its people. This being a common norm in the world of business, several of them are taking healthy initiatives and opening discussions around gender diversity and equality.

Panelists during a session on Empowering Women In the Workplace held during the Pharmacy Business Diversity Conference on Thursday (December 9), agreed that having gender diversity in business, not just benefits women, but the whole organization.


“It drives engagement, diversity of thinking and ultimately performance,” said Ifti Khan, pharmacy superintendent at Well Pharmacy, in the session moderated by the conference chair and BBC presenter Clive Myrie.

To substantiate his point, he cited a recent report by McKinsey & Company, as per which companies in the top quartile for ethnic and cultural diversity are 36 per cent more profitable than those in the fourth quartile.

He said: “Women make up such a large proportion of our workforce in the pharmacy industry, even more in patient facing roles. And so it's important for us to ensure women are engaged and empowered at work.”

Myrie observed that despite several initiatives by corporates, the dial for gender equity is not “moving as fast as it should be. It isn't moving as fast as the stats suggest,” causing a logjam.

Agreeing with Myrie’s comment, Silke Heinrichs Global D&I partner at Roche Diagnostics GmbH said a log jam still seems to be there, especially in company boards, footsie 100 firms, etc.

She said various root causes and stereotypes like “think manager think male” pose a big challenge in rectifying this.

She added that at the career front, women face a competitive disadvantage as a lot of caring related responsibilities still rest with women.

She highlighted that women do not have a level playing field in professional space as after childbirth they return to work mostly with 50 per cent time.

“And of course, it's very difficult to thrive and to shine and to get the coolest projects. If you're out for at least a year or longer, and then you return 50 per cent. It's difficult to progress in your career.”

To correct this situation, Heinrichs said, Roche has started a new initiative in September, under which the firm pays incentive if a new mothers returns earlier with more working hours per week and fathers reduce their working time to share the child care duty.

The idea is to influence society as a whole and bring a behavioural change.

Talking about initiatives at Well Pharmacy, Khan said: “We are in the process of developing our culture code. And over the last few months, we've approached everyone across the organisation to feed into that it's about core creation.”

It will give people an opportunity to come forward and express, he said.

Besides, the pharmacy chain has set up an inclusion working group involving colleagues from across the sector to develop a diversity and inclusion strategy.

“We're at the very early stages, but we've started on that journey, which is the most important thing,” Khan added.

During the discussion, Celeste Warren, vice president Global Diversity & Inclusion at Merck's Centre of Excellence noted that various life stages of women are very critical at the workplace, and it is the obligation of an organization to meet the needs of the women through these stages.

She informed that to understand such needs, Merck sends out a survey to employees.

Through this survey the company asks a “plethora of different questions and get that information back and then puts programmes in place,” she said.

Warren said these surveys are important to determine the needs of various dimensions of diversity that exist within the gender, based on sexuality, colour, disability, etc.

“If we don't take a multidimensional approach, we aren't going to meet the needs of gender parity. At MSD we are working very hard to try to create that gender inclusive environment,” Warren added.

More For You

How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less